BPMC

Blueprint Medicines Corp

• Benzinga·07/22/2025 18:09

  Sanofi Expands Respiratory Vaccine Portfolio With UK Biotech Buy

• TipRanks·07/18/2025 10:32

  Cogent Biosciences price target raised to $22 from $15 at Citi

• TipRanks·07/18/2025 10:29

  Blueprint Medicines Completes $9.1B Merger, Delists from Nasdaq

• Reuters·07/18/2025 10:10

  Sanofi to Acquire Blueprint Medicines Corporation Following Successful Tender Offer Completion

• Reuters·07/18/2025 10:04

  Sanofi Finalizes Acquisition of Blueprint Medicines, Expanding Immunology Portfolio

• Reuters·07/18/2025 05:00

  Sanofi SA Acquires Blueprint Medicines, Establishing New Subsidiary Focused on Rare Immunology Diseases

• Reuters·07/17/2025 05:03

  BRIEF-Sanofi Announces Extension Of Blueprint Tender Offer

• Reuters·07/17/2025 05:00

  Rothko Merger Sub, Inc., a Sanofi Subsidiary, Extends Tender Offer for Blueprint Medicines

• NASDAQ·07/16/2025 20:24

  After Hours Most Active for Jul 16, 2025 : SRPT, NVDA, AAPL, BPMC, PFE, QQQ, INTC, CNH, GE, NI, WFC, F

• Benzinga·07/14/2025 19:01

  What's Driving the Market Sentiment Around Blueprint Medicines?

• TipRanks·07/09/2025 02:01

  Top Executives at Blueprint Medicines Make Significant Stock Sales!

• Reuters·07/08/2025 20:20

  Christina Rossi, COO, Reports Disposal of Common Shares in Blueprint Medicines Corporation

• Reuters·07/08/2025 20:20

  Chief Scientific Officer Percy H. Carter Reports Disposal of Common Shares of Blueprint Medicines Corporation

• Benzinga·07/08/2025 18:26

  Cogent's Chronic Immune Disorder Drug Has Strong Potential To Become A Blockbuster: Analyst

• NASDAQ·07/08/2025 14:01

  BPMC Quantitative Stock Analysis